Adamax
Also known as: N-acetyl Semax amidate adamantylated
Adamax is a grey-market nootropic peptide developed and sold by the Mexico-based vendor Ceretropic. It is marketed as a Semax derivative: N-acetyl Semax amide (Ac-MEHFPGP-NH2) with an adamantane (adamantyl-glycine) moiety appended at the C-terminus, reportedly intended to improve metabolic stability and blood-brain-barrier penetration. It is NOT an ADNP / NAP / davunetide analog despite some online descriptions conflating it with those compounds. Adamax has no indexed peer-reviewed literature of its own; all claimed effects are extrapolated from Semax data plus anecdotal user reports.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for Adamax
6 third-party tests across 1 vendor. Each card links to the full report.
For
Adamax
by Skye Peptides· batch ADA26-10-001
For
Adamax
by Skye Peptides· batch ADA25-10-001
Purity not on file
For
Adamax
by Skye Peptides· batch ADA26-10-001
Purity not on file
For
Adamax
by Skye Peptides· batch ADA26-10-001
Purity not on file
For
Adamax
by Skye Peptides· batch ADA25-10-001
Purity not on file
For
Adamax
by Skye Peptides· batch ADA25-10-001